Global Prostatic Artery Embolization Market 2018 | Global (North America, Europe, Middle East and Africa, Latin America and the Asia Pacific) Market Status and Forecast 2025

PAE is a non-surgical way of treating an enlarged and troublesome prostate by blocking off the arteries that feed the gland and making it shrink. It is performed by an interventional radiologist, rather than a surgeon, and is an alternative to a TURP (trans urethral resection of prostate) operation. PAE was first performed in 2009, and since then over 200 men have had the procedure performed predominantly in Portugal and Brazil. University Hospital Southampton has been offering a PAE service from April 2012 and is the first UK centre to perform this procedure.

Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2674390?utm_source=OPR&utm_medium=Anil

This report studies the Prostatic Artery Embolization market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Prostatic Artery Embolization market by product type and applications/end industries.

The global Prostatic Artery Embolization market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Prostatic Artery Embolization.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers UNC Health Care, Tampa General Hospital, Henry Ford, Spire Healthcare

Market Segment by Regions, regional analysis covers
• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
• Type 1
• Type 2

Market Segment by Applications, can be divided into
• Yonger than 60
• 60-85
• Older than 85

Get a discount on this research report @ https://www.bigmarketresearch.com/request-for-discount/2674390?utm_source=OPR&utm_medium=Anil

Table of Contents
1 Prostatic Artery Embolization Market Overview
1.1 Product Overview and Scope of Prostatic Artery Embolization
1.2 Classification of Prostatic Artery Embolization by Types
1.2.1 Global Prostatic Artery Embolization Revenue Comparison by Types (2017-2023)
1.2.2 Global Prostatic Artery Embolization Revenue Market Share by Types in 2017
1.2.3 Type 1
1.2.4 Type 2
1.3 Global Prostatic Artery Embolization Market by Application
1.3.1 Global Prostatic Artery Embolization Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Yonger than 60
1.3.3 60-85
1.3.4 Older than 85
1.4 Global Prostatic Artery Embolization Market by Regions
1.4.1 Global Prostatic Artery Embolization Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Prostatic Artery Embolization Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Prostatic Artery Embolization Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prostatic Artery Embolization Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Prostatic Artery Embolization Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prostatic Artery Embolization Status and Prospect (2013-2023)
1.5 Global Market Size of Prostatic Artery Embolization (2013-2023)
2 Manufacturers Profiles
2.1 UNC Health Care
2.1.1 Business Overview
2.1.2 Prostatic Artery Embolization Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 UNC Health Care Prostatic Artery Embolization Revenue, Gross Margin and Market Share (2016-2017)
2.2 Tampa General Hospital
2.2.1 Business Overview
2.2.2 Prostatic Artery Embolization Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Tampa General Hospital Prostatic Artery Embolization Revenue, Gross Margin and Market Share (2016-2017)
2.3 Henry Ford
2.3.1 Business Overview
2.3.2 Prostatic Artery Embolization Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Henry Ford Prostatic Artery Embolization Revenue, Gross Margin and Market Share (2016-2017)
2.4 Spire Healthcare
2.4.1 Business Overview
2.4.2 Prostatic Artery Embolization Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Spire Healthcare Prostatic Artery Embolization Revenue, Gross Margin and Market Share (2016-2017)

Inquiry before Buy @ https://www.bigmarketresearch.com/purchase-enquiry/2674390?utm_source=OPR&utm_medium=Anil

About Us:
Industry executives tend to keep a tab on their business competitors. This keeps them updated on strategic business activities and investment trends. Company profiles are crucial to participating players of interconnected verticals.

Contact Us:
5933 NE Win Sivers Drive, #205, Portland,
OR 97220 United States
Call answer Direct: +1-971-202-1575
Call answer Toll Free: +1-800-910-6452
Email help@bigmarketresearch.com

This release was published on openPR.